Log in

OTCMKTS:PCSAProcessa Pharmaceuticals Stock Price, Forecast & News

0.00 (0.00 %)
(As of 06/5/2020 04:00 PM ET)
Today's Range
Now: $8.00
50-Day Range
MA: $7.64
52-Week Range
Now: $8.00
Average Volume326 shs
Market Capitalization$44.88 million
P/E RatioN/A
Dividend YieldN/A
Processa Pharmaceuticals, Inc., a pharmaceutical company, engages in the clinical development of drug products for the unmet medical needs. Its lead product candidate is PCS-499, an oral tablet for the treatment of necrobiosis lipoidica and radiation-induced fibrosis in head and neck cancer patients. The company is based in Hanover, Maryland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:PCSA
Previous SymbolOTCMKTS:HUWX



Sales & Book Value

Annual SalesN/A
Book Value$1.46 per share


Net Income$-3,360,000.00


Market Cap$44.88 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive PCSA News and Ratings via Email

Sign-up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.

Processa Pharmaceuticals (OTCMKTS:PCSA) Frequently Asked Questions

How has Processa Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Processa Pharmaceuticals' stock was trading at $9.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PCSA shares have decreased by 17.9% and is now trading at $8.00. View which stocks have been most impacted by Coronavirus.

When is Processa Pharmaceuticals' next earnings date?

Processa Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Processa Pharmaceuticals.

How were Processa Pharmaceuticals' earnings last quarter?

Processa Pharmaceuticals Inc (OTCMKTS:PCSA) announced its quarterly earnings data on Monday, May, 21st. The company reported ($0.03) earnings per share (EPS) for the quarter. View Processa Pharmaceuticals' earnings history.

Has Processa Pharmaceuticals been receiving favorable news coverage?

News headlines about PCSA stock have trended positive this week, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Processa Pharmaceuticals earned a news impact score of 2.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutProcessa Pharmaceuticals.

Who are some of Processa Pharmaceuticals' key competitors?

Who are Processa Pharmaceuticals' key executives?

Processa Pharmaceuticals' management team includes the following people:
  • Dr. David Young, Co- Founder, Chairman & CEO (Age 66)
  • Mr. Patrick Lin, Co-Founder, Chief Bus. & Strategy Officer and Director (Age 54)
  • Dr. Sian E. Bigora, Co-Founder & Chief Devel. Officer (Age 59)
  • Ms. Wendy Guy, Co-Founder & Chief Admin. Officer (Age 55)
  • Mr. James H. Stanker, Chief Financial Officer (Age 61)

What is Processa Pharmaceuticals' stock symbol?

Processa Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PCSA."

How do I buy shares of Processa Pharmaceuticals?

Shares of PCSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Processa Pharmaceuticals' stock price today?

One share of PCSA stock can currently be purchased for approximately $8.00.

How big of a company is Processa Pharmaceuticals?

Processa Pharmaceuticals has a market capitalization of $44.88 million. Processa Pharmaceuticals employs 15 workers across the globe.

What is Processa Pharmaceuticals' official website?

The official website for Processa Pharmaceuticals is www.processapharmaceuticals.com.

How can I contact Processa Pharmaceuticals?

Processa Pharmaceuticals' mailing address is 7380 COCA COLA DRIVE SUITE 106, HANOVER MD, 21076. The company can be reached via phone at 443-776-3133 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.